Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bruno Cantilena"'
Autor:
Fabiana Passaro, Tommaso Russo, Carmine Cozzolino, Bruno Cantilena, Francesca Querques, Lucio Pastore, Barbara Lombardo, Maria Teresa Esposito, Silvia Parisi
Publikováno v:
Journal of Cellular Physiology. 230:1466-1474
Clinical studies of large human populations and pharmacological interventions in rodent models have recently suggested that anti-hypertensive drugs that target angiotensin II (Ang II) activity may also reduce loss of bone mineral density. Here, we id
Autor:
Adelaide Greco, Arturo Brunetti, Sara Gargiulo, Maria Teresa Esposito, Teresa Rocco, Donatella Montanaro, Lucio Pastore, Barbara Lombardo, Bruno Cantilena
Publikováno v:
Current gene therapy
13 (2013): 202–210.
info:cnr-pdr/source/autori:Lombardo, Barbara; Rocco, Teresa; Esposito, Maria T.; Cantilena, Bruno; Gargiulo, Sara; Greco, Adelaide; Montanaro, Donatella; Brunetti, Arturo; Pastore, Lucio/titolo:Thymidine Kinase-Mediated Shut Down of Bone Morphogenetic Protein-4 Expression Allows Regulated Bone Production/doi:/rivista:Current gene therapy (Print)/anno:2013/pagina_da:202/pagina_a:210/intervallo_pagine:202–210/volume:13
13 (2013): 202–210.
info:cnr-pdr/source/autori:Lombardo, Barbara; Rocco, Teresa; Esposito, Maria T.; Cantilena, Bruno; Gargiulo, Sara; Greco, Adelaide; Montanaro, Donatella; Brunetti, Arturo; Pastore, Lucio/titolo:Thymidine Kinase-Mediated Shut Down of Bone Morphogenetic Protein-4 Expression Allows Regulated Bone Production/doi:/rivista:Current gene therapy (Print)/anno:2013/pagina_da:202/pagina_a:210/intervallo_pagine:202–210/volume:13
Bone morphogenetic Proteins (BMPs) are growth factors also involved in ossification and chondrogenesis that have generated interest for their efficiency in inducing bone neo-synthesis. BMPs expression in engineered cells has been successful in stimul
Autor:
Francesca, Querques, Bruno, Cantilena, Carmine, Cozzolino, Maria Teresa, Esposito, Fabiana, Passaro, Silvia, Parisi, Barbara, Lombardo, Tommaso, Russo, Lucio, Pastore
Publikováno v:
Journal of cellular physiology. 230(7)
Clinical studies of large human populations and pharmacological interventions in rodent models have recently suggested that anti-hypertensive drugs that target angiotensin II (Ang II) activity may also reduce loss of bone mineral density. Here, we id